Optimal Duration of Low Molecular Weight Heparin for the Treatment ofCancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study.

Mariasanta Napolitano, Sergio Siragusa, Alessandra Casuccio, Salvatrice Mancuso, Giovam Battista Rini, Vincenzo Oriana, Stefano Rotondo, Eugenio Bucherini, Francesco Recchia, Davide Imberti, Andrea D'Alessio, Doris Mascheroni, Pina Gallucci, Oreste Urbano, Tullia Prantera, Oreste Urbano, Angelo Ghirarduzzi, Pierpaolo Di Micco, Pietro Spadaro, Walter AgenoDelia Sprini

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Optimal Duration of Low Molecular Weight Heparin for the Treatment ofCancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study.'. Together they form a unique fingerprint.

Medicine & Life Sciences